CombiMatrix Corporation to Release 2016 First Quarter Financial Results on May 4, 2016
April 27, 2016 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., April 27, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) announces that it will release financial results for the three months ended March 31, 2016 after market close...
CombiMatrix Notes Two Additional Blue Cross Blue Shield Health Plans Revise Medical Policies to Reimburse for Recurrent Pregnancy Loss Testing
April 26, 2016 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., April 26, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for pre-implantation genetic...
CombiMatrix Provides Strategic Update
April 21, 2016 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., April 21, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix Launches Preimplantation Genetic Diagnostic Testing for Single Gene Disorders and Chromosomal Translocations
April 05, 2016 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., April 05, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix Comments on Medical Policy Revisions by Cigna Health and Three BCBS Health Plans to Reimburse for Recurrent Pregnancy Loss Testing
March 29, 2016 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., March 29, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix Closes $8.0 Million Underwritten Public Offering
March 24, 2016 09:59 ET
|
CombiMatrix Corporation
IRVINE, Calif., March 24, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
ACOG and SMFM Update Practice Bulletins Recommending Prenatal Genetic Assessment for All Pregnant Women Regardless of Age or Other Risk Factors
March 23, 2016 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., March 23, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix Prices $8.0 Million Underwritten Public Offering
March 21, 2016 08:11 ET
|
CombiMatrix Corporation
IRVINE, Calif., March 21, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix to Present at the ROTH Conference
March 09, 2016 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., March 09, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix Forms Scientific Advisory Board; Includes Leaders in Reproductive Health, Pathology, Genetics, Molecular Biology and Health Policy
February 26, 2016 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Feb. 26, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...